RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 69 filers reported holding RECRO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $266,000 | -63.0% | 24,051 | -66.0% | 0.03% | -32.0% |
| Q2 2019 | $719,000 | +215.4% | 70,700 | +81.6% | 0.05% | +354.5% |
| Q1 2019 | $228,000 | -24.5% | 38,925 | -8.6% | 0.01% | -35.3% |
| Q3 2018 | $302,000 | -49.1% | 42,600 | -64.0% | 0.02% | -51.4% |
| Q2 2018 | $593,000 | +111.0% | 118,200 | +270.5% | 0.04% | +52.2% |
| Q3 2016 | $281,000 | -9.1% | 31,900 | -18.0% | 0.02% | -20.7% |
| Q2 2016 | $309,000 | -21.6% | 38,900 | -41.1% | 0.03% | -27.5% |
| Q1 2016 | $394,000 | -35.4% | 66,094 | -2.5% | 0.04% | -48.7% |
| Q4 2015 | $610,000 | +6.8% | 67,800 | +42.4% | 0.08% | +5.4% |
| Q3 2015 | $571,000 | +151.5% | 47,600 | +170.5% | 0.07% | +131.2% |
| Q2 2015 | $227,000 | – | 17,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |